116 related articles for article (PubMed ID: 23135668)
1. Topical pimecrolimus 1% reverses long-term suberythemal ultraviolet B-induced epidermal Langerhans cell reduction and morphologic changes in mice.
Yin Z; Xu J; Lu Y; Luo D
J Drugs Dermatol; 2012 Sep; 11(9):e25-7. PubMed ID: 23135668
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells.
Yin Z; Xu J; Zhang Z; Luo D
Int Immunopharmacol; 2012 Dec; 14(4):635-40. PubMed ID: 23079131
[TBL] [Abstract][Full Text] [Related]
3. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation.
Lerche CM; Philipsen PA; Poulsen T; Wulf HC
Exp Dermatol; 2009 Mar; 18(3):246-51. PubMed ID: 19183401
[TBL] [Abstract][Full Text] [Related]
4. Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis.
Tran C; Lübbe J; Sorg O; Doelker L; Carraux P; Antille C; Grand D; Leemans E; Kaya G; Saurat JH
Dermatology; 2005; 211(4):341-7. PubMed ID: 16286744
[TBL] [Abstract][Full Text] [Related]
5. Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin.
Yin Z; Xu J; Zhou B; Wu D; Xu Y; Zhang J; Luo D
Drug Des Devel Ther; 2014; 8():1817-25. PubMed ID: 25336924
[TBL] [Abstract][Full Text] [Related]
6. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
7. Repeated irradiation with suberythemal ultraviolet B reduces the number of epidermal Langerhans cells.
Ishitsuka Y; Masunaga T; Koide C; Arakane K
Arch Dermatol Res; 2003 Aug; 295(4):155-9. PubMed ID: 12844227
[TBL] [Abstract][Full Text] [Related]
8. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure.
Martires KJ; Domingo DS; Hsia A; Fu P; Cooper KD; Baron ED
Exp Dermatol; 2011 Mar; 20(3):280-2. PubMed ID: 21166722
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical tacrolimus 0.03% on long-term suberythemal ultraviolet B-irradiated epidermal Langerhans cells in mice.
Yin ZQ; Lu Y; Zhou BR; Guo Z; Luo D
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):521-3. PubMed ID: 22471949
[No Abstract] [Full Text] [Related]
10. Protective effects of cyclooxygenase-2 inhibitors on narrow-band ultraviolet B-irradiated epidermal Ia+ Langerhans cells and Thy-1+ dendritic epidermal T cells in mice.
Wu Y; Tai CL; Wei H; He F; Wang Y; Zhao Y; Chen HD
Photochem Photobiol; 2008; 84(2):484-8. PubMed ID: 18266820
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus Reverses UVB Irradiation-Induced Epidermal Langerhans Cell Reduction by Inhibiting TNF-α Secretion in Keratinocytes via Regulation of NF-κB/p65.
Xu J; Feng Y; Song G; Gong Q; Yin L; Hu Y; Luo D; Yin Z
Front Pharmacol; 2018; 9():67. PubMed ID: 29520229
[No Abstract] [Full Text] [Related]
12. Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in mouse skin.
Lu YP; Lou YR; Li XH; Xie JG; Lin Y; Shih WJ; Conney AH
Oncol Res; 2002; 13(2):61-70. PubMed ID: 12392153
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells.
Hoetzenecker W; Meingassner JG; Ecker R; Stingl G; Stuetz A; Elbe-Bürger A
J Invest Dermatol; 2004 Mar; 122(3):673-84. PubMed ID: 15086553
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus in combination with simulated solar radiation does not enhance photocarcinogenesis in hairless mice.
Lerche CM; Philipsen PA; Poulsen T; Wulf HC
Exp Dermatol; 2008 Jan; 17(1):57-62. PubMed ID: 18095946
[TBL] [Abstract][Full Text] [Related]
15. Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients.
Doelker L; Tran C; Gkomouzas A; Grand D; Sorg O; Saurat JH; Lübbe J
Exp Dermatol; 2006 May; 15(5):342-6. PubMed ID: 16630073
[TBL] [Abstract][Full Text] [Related]
16. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
17. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression.
Yoshiki R; Kabashima K; Sakabe J; Sugita K; Bito T; Nakamura M; Malissen B; Tokura Y
J Immunol; 2010 May; 184(10):5670-7. PubMed ID: 20400709
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells.
Tang A; Udey MC
J Immunol; 1991 May; 146(10):3347-55. PubMed ID: 1673983
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Langerhans cells and Thy-1+ dendritic epidermal cells in murine epidermis during the evolution of ultraviolet radiation-induced skin cancers.
Alcalay J; Craig JN; Kripke ML
Cancer Res; 1989 Aug; 49(16):4591-6. PubMed ID: 2568173
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus does not affect Langerhans cells in murine epidermis.
Meingassner JG; Kowalsky E; Schwendinger H; Elbe-Bürger A; Stütz A
Br J Dermatol; 2003 Oct; 149(4):853-7. PubMed ID: 14616380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
